ðŸ¦¥ Unsloth: Will patch your computer to enable 2x faster free finetuning.
Unsloth: Failed to patch Gemma3ForConditionalGeneration.
ðŸ¦¥ Unsloth Zoo will now patch everything to make training faster!
INFO 04-14 05:34:04 [__init__.py:239] Automatically detected platform cuda.
/home/u111169/mgh/grpo_0.py:11: FutureWarning: A value is trying to be set on a copy of a DataFrame or Series through chained assignment using an inplace method.
The behavior will change in pandas 3.0. This inplace method will never work because the intermediate object on which we are setting values always behaves as a copy.

For example, when doing 'df[col].method(value, inplace=True)', try using 'df.method({col: value}, inplace=True)' or df[col] = df[col].method(value) instead, to perform the operation inplace on the original object.


  df["labels"].replace({"<APPROVED>":"approved" , "<NOT APPROVED>":"unapproved"} , inplace=True)
==((====))==  Unsloth 2025.3.19: Fast Llama patching. Transformers: 4.51.1. vLLM: 0.8.3.
   \\   /|    Tesla V100-PCIE-32GB. Num GPUs = 1. Max memory: 31.739 GB. Platform: Linux.
O^O/ \_/ \    Torch: 2.6.0+cu124. CUDA: 7.0. CUDA Toolkit: 12.4. Triton: 3.2.0
\        /    Bfloat16 = FALSE. FA [Xformers = 0.0.29.post3. FA2 = False]
 "-____-"     Free license: http://github.com/unslothai/unsloth
Unsloth: Fast downloading is enabled - ignore downloading bars which are red colored!
Unsloth: Your GPU does not support prefix caching - will disable!
Unsloth: vLLM loading /home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659 with actual GPU utilization = 58.3%
Unsloth: Your GPU has CUDA compute capability 7.0 with VRAM = 31.74 GB.
Unsloth: Using conservativeness = 1.0. Chunked prefill tokens = 5000. Num Sequences = 160.
Unsloth: vLLM's KV Cache can use up to 3.47 GB. Also swap space = 6 GB.
WARNING 04-14 05:34:07 [config.py:2704] Casting torch.bfloat16 to torch.float16.
INFO 04-14 05:34:15 [config.py:600] This model supports multiple tasks: {'embed', 'generate', 'reward', 'classify', 'score'}. Defaulting to 'generate'.
WARNING 04-14 05:34:15 [arg_utils.py:1708] Compute Capability < 8.0 is not supported by the V1 Engine. Falling back to V0. 
Unsloth: vLLM Bitsandbytes config using kwargs = {'load_in_8bit': False, 'load_in_4bit': True, 'bnb_4bit_compute_dtype': 'float16', 'bnb_4bit_quant_storage': 'uint8', 'bnb_4bit_quant_type': 'fp4', 'bnb_4bit_use_double_quant': False, 'llm_int8_enable_fp32_cpu_offload': False, 'llm_int8_has_fp16_weight': False, 'llm_int8_skip_modules': [], 'llm_int8_threshold': 6.0}
INFO 04-14 05:34:15 [llm_engine.py:242] Initializing a V0 LLM engine (v0.8.3) with config: model='/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659', speculative_config=None, tokenizer='/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659', skip_tokenizer_init=False, tokenizer_mode=auto, revision=None, override_neuron_config=None, tokenizer_revision=None, trust_remote_code=False, dtype=torch.float16, max_seq_len=5000, download_dir=None, load_format=LoadFormat.BITSANDBYTES, tensor_parallel_size=1, pipeline_parallel_size=1, disable_custom_all_reduce=False, quantization=bitsandbytes, enforce_eager=False, kv_cache_dtype=auto,  device_config=cuda:0, decoding_config=DecodingConfig(guided_decoding_backend='xgrammar', reasoning_backend=None), observability_config=ObservabilityConfig(show_hidden_metrics=False, otlp_traces_endpoint=None, collect_model_forward_time=False, collect_model_execute_time=False), seed=0, served_model_name=/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659, num_scheduler_steps=1, multi_step_stream_outputs=True, enable_prefix_caching=False, chunked_prefill_enabled=False, use_async_output_proc=True, disable_mm_preprocessor_cache=False, mm_processor_kwargs=None, pooler_config=None, compilation_config={"level":0,"splitting_ops":[],"compile_sizes":[],"cudagraph_capture_sizes":[160,152,144,136,128,120,112,104,96,88,80,72,64,56,48,40,32,24,16,8,4,2,1],"max_capture_size":160}, use_cached_outputs=False, 
/share/apps/eb/Python/3.11.5-GCCcore-13.2.0/envs/vllm/lib/python3.11/site-packages/vllm/executor/uniproc_executor.py:29: UserWarning: Failed to get the IP address, using 0.0.0.0 by default.The value can be set by the environment variable VLLM_HOST_IP or HOST_IP.
  get_ip(), get_open_port())
INFO 04-14 05:34:15 [cuda.py:240] Cannot use FlashAttention-2 backend for Volta and Turing GPUs.
INFO 04-14 05:34:15 [cuda.py:289] Using XFormers backend.
[W414 05:34:16.666822475 socket.cpp:204] [c10d] The hostname of the client socket cannot be retrieved. err=-3
[W414 05:34:16.667130803 socket.cpp:204] [c10d] The hostname of the client socket cannot be retrieved. err=-3
INFO 04-14 05:34:16 [parallel_state.py:957] rank 0 in world size 1 is assigned as DP rank 0, PP rank 0, TP rank 0
INFO 04-14 05:34:16 [model_runner.py:1110] Starting to load model /home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659...
INFO 04-14 05:34:16 [loader.py:1155] Loading weights with BitsAndBytes quantization. May take a while ...
Loading safetensors checkpoint shards:   0% Completed | 0/4 [00:00<?, ?it/s]
Loading safetensors checkpoint shards:  25% Completed | 1/4 [00:00<00:00,  6.32it/s]
Loading safetensors checkpoint shards:  50% Completed | 2/4 [00:00<00:00,  2.09it/s]
Loading safetensors checkpoint shards:  75% Completed | 3/4 [00:01<00:00,  1.70it/s]
Loading safetensors checkpoint shards: 100% Completed | 4/4 [00:02<00:00,  1.60it/s]
Loading safetensors checkpoint shards: 100% Completed | 4/4 [00:02<00:00,  1.77it/s]

INFO 04-14 05:34:18 [punica_selector.py:18] Using PunicaWrapperGPU.
INFO 04-14 05:34:18 [model_runner.py:1146] Model loading took 5.4442 GiB and 2.449135 seconds
INFO 04-14 05:34:29 [worker.py:267] Memory profiling takes 10.47 seconds
INFO 04-14 05:34:29 [worker.py:267] the current vLLM instance can use total_gpu_memory (31.74GiB) x gpu_memory_utilization (0.58) = 18.50GiB
INFO 04-14 05:34:29 [worker.py:267] model weights take 5.44GiB; non_torch_memory takes 0.14GiB; PyTorch activation peak memory takes 0.77GiB; the rest of the memory reserved for KV Cache is 12.14GiB.
INFO 04-14 05:34:29 [executor_base.py:112] # cuda blocks: 6217, # CPU blocks: 3072
INFO 04-14 05:34:29 [executor_base.py:117] Maximum concurrency for 5000 tokens per request: 19.89x
INFO 04-14 05:34:32 [model_runner.py:1456] Capturing cudagraphs for decoding. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI. If out-of-memory error occurs during cudagraph capture, consider decreasing `gpu_memory_utilization` or switching to eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.
Capturing CUDA graph shapes:   0%|          | 0/23 [00:00<?, ?it/s]Capturing CUDA graph shapes:   4%|â–         | 1/23 [00:01<00:34,  1.56s/it]Capturing CUDA graph shapes:   9%|â–Š         | 2/23 [00:02<00:31,  1.48s/it]Capturing CUDA graph shapes:  13%|â–ˆâ–Ž        | 3/23 [00:04<00:29,  1.46s/it]Capturing CUDA graph shapes:  17%|â–ˆâ–‹        | 4/23 [00:05<00:27,  1.44s/it]Capturing CUDA graph shapes:  22%|â–ˆâ–ˆâ–       | 5/23 [00:07<00:24,  1.39s/it]Capturing CUDA graph shapes:  26%|â–ˆâ–ˆâ–Œ       | 6/23 [00:08<00:23,  1.36s/it]Capturing CUDA graph shapes:  30%|â–ˆâ–ˆâ–ˆ       | 7/23 [00:09<00:21,  1.35s/it]Capturing CUDA graph shapes:  35%|â–ˆâ–ˆâ–ˆâ–      | 8/23 [00:11<00:19,  1.33s/it]Capturing CUDA graph shapes:  39%|â–ˆâ–ˆâ–ˆâ–‰      | 9/23 [00:12<00:18,  1.32s/it]Capturing CUDA graph shapes:  43%|â–ˆâ–ˆâ–ˆâ–ˆâ–Ž     | 10/23 [00:13<00:16,  1.31s/it]Capturing CUDA graph shapes:  48%|â–ˆâ–ˆâ–ˆâ–ˆâ–Š     | 11/23 [00:14<00:15,  1.30s/it]Capturing CUDA graph shapes:  52%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–    | 12/23 [00:16<00:14,  1.30s/it]Capturing CUDA graph shapes:  57%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‹    | 13/23 [00:17<00:12,  1.24s/it]Capturing CUDA graph shapes:  61%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    | 14/23 [00:18<00:10,  1.21s/it]Capturing CUDA graph shapes:  65%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–Œ   | 15/23 [00:19<00:09,  1.18s/it]Capturing CUDA graph shapes:  70%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‰   | 16/23 [00:20<00:08,  1.16s/it]Capturing CUDA graph shapes:  74%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–  | 17/23 [00:21<00:06,  1.16s/it]Capturing CUDA graph shapes:  78%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–Š  | 18/23 [00:22<00:05,  1.15s/it]Capturing CUDA graph shapes:  83%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–Ž | 19/23 [00:24<00:04,  1.14s/it]Capturing CUDA graph shapes:  87%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‹ | 20/23 [00:25<00:03,  1.13s/it]Capturing CUDA graph shapes:  91%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–| 21/23 [00:26<00:02,  1.12s/it]Capturing CUDA graph shapes:  96%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–Œ| 22/23 [00:27<00:01,  1.12s/it]Capturing CUDA graph shapes: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 23/23 [00:28<00:00,  1.00it/s]Capturing CUDA graph shapes: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 23/23 [00:28<00:00,  1.22s/it]
INFO 04-14 05:35:02 [model_runner.py:1598] Graph capturing finished in 30 secs, took 3.07 GiB
INFO 04-14 05:35:02 [llm_engine.py:448] init engine (profile, create kv cache, warmup model) took 43.76 seconds
/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659 does not have a padding token! Will use pad_token = <|finetune_right_pad_id|>.
Unsloth 2025.3.19 patched 32 layers with 32 QKV layers, 32 O layers and 32 MLP layers.
Map:   0%|          | 0/2497 [00:00<?, ? examples/s]Map:  69%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–Š   | 1711/2497 [00:00<00:00, 17021.71 examples/s]Map: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 2497/2497 [00:00<00:00, 15495.18 examples/s]
Unsloth: We now expect `per_device_train_batch_size` to be a multiple of `num_generations`.
We will change the batch size of 1 to the `num_generations` of 4
WARNING:accelerate.utils.other:Detected kernel version 5.3.18, which is below the recommended minimum of 5.5.0; this can cause the process to hang. It is recommended to upgrade the kernel to the minimum version or higher.
==((====))==  Unsloth - 2x faster free finetuning | Num GPUs used = 1
   \\   /|    Num examples = 2,497 | Num Epochs = 1 | Total steps = 20
O^O/ \_/ \    Batch size per device = 4 | Gradient accumulation steps = 1
\        /    Data Parallel GPUs = 1 | Total batch size (4 x 1 x 1) = 4
 "-____-"     Trainable parameters = 41,943,040/8,000,000,000 (0.52% trained)
  0%|          | 0/20 [00:00<?, ?it/s]--------------------
Question:

            I have developed a model that can predict the drug approval of compound X.
            This model outputs two lists containting the properties of most similar approved and unapproved modelcules
            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 263.38, 'LogP': 2.63, 'Molecular Refractivity': 77.4, 'TPSA': 32.7, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 2, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.99, 'Rdkit information': {'Molecular Weight': 263.38, 'LogP': 2.63, 'Molecular Refractivity': 77.4, 'TPSA': 32.70, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.98, 'Rdkit information': {'Molecular Weight': 299.84, 'LogP': 3.06, 'Molecular Refractivity': 84.65, 'TPSA': 32.70, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 20, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 237.73, 'LogP': 2.9, 'Molecular Refractivity': 65.66, 'TPSA': 29.10, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 16, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 309.41, 'LogP': 3.42, 'Molecular Refractivity': 93.94, 'TPSA': 30.29, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 23, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['Aliphatic_long_chain']}}, 5: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 264.37, 'LogP': 2.62, 'Molecular Refractivity': 78.68, 'TPSA': 41.57, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['Aliphatic_long_chain']}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 281.42, 'LogP': 2.68, 'Molecular Refractivity': 78.26, 'TPSA': 37.38, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 315.84, 'LogP': 4.38, 'Molecular Refractivity': 94.71, 'TPSA': 12.47, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 22, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 341.45, 'LogP': 3.24, 'Molecular Refractivity': 100.2, 'TPSA': 58.56, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 11, 'Chiral Centers': 1, 'Heavy Atoms': 25, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain']}}, 4: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 295.85, 'LogP': 4.17, 'Molecular Refractivity': 85.5, 'TPSA': 12.47, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 20, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain']}}, 5: { 'similarity score': 0.91, 'Rdkit information': {'Molecular Weight': 313.87, 'LogP': 4.59, 'Molecular Refractivity': 97.79, 'TPSA': 3.24, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 22, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['styrene_A(13)']}}}}
            


Answer


:
approved


Response


:
<think>
To determine the likelihood of compound X receiving regulatory approval based on its similarity to known molecules, we need to analyze the provided data.

Compound X has a molecular weight of 263.38, logP of 2.63, molecular refractivity of 77.4, TPSA of 32.7, 1 hydrogen bond donor, 3 hydrogen bond acceptors, 4 rotatable bonds, 2 chiral centers, 19 heavy atoms, a formal charge of 0, 2 total rings, and no structural alerts.

The most similar approved drugs to Compound X are:

- Drug 1 with a similarity score of 0.99, having a molecular weight of 263.38, logP of 2.63, molecular refractivity of 77.4, TPSA of 32.7, 1 hydrogen bond donor, 3 hydrogen bond acceptors, 4 rotatable bonds, 0 chiral centers, 19 heavy atoms, a formal charge of 0, 2 total rings, and no structural alerts.
- Drug 2 with a similarity score of 0.98, having a molecular weight of 299.84, logP of 3.06, molecular refractivity of 84.65, TPSA of 32.7, 1 hydrogen bond donor, 3 hydrogen bond acceptors, 4 rotatable bonds, 0 chiral centers, 20 heavy atoms, a formal charge of 0, 2 total rings, and no structural alerts.
- Drug 3 with a similarity score of 0.95, having a molecular weight of 237.73, logP of 2.9, molecular refractivity of 65.66, TPSA of 29.1, 1 hydrogen bond donor, 2 hydrogen bond acceptors, 2 rotatable bonds, 0 chiral centers, 16 heavy atoms, a formal charge of 0, 2 total rings, and no structural alerts.
- Drug 4 with a similarity score of 0.94, having a molecular weight of 309.41, logP of 3.42, molecular refractivity of 93.94, TPSA of 30.29, 0 hydrogen bond donors, 4 hydrogen bond acceptors, 7 rotatable bonds, 0 chiral centers, 23 heavy atoms, a formal charge of 0, 3 total rings, and aliphatic_long_chain structural alerts.
- Drug 5 with a similarity score of 0.94, having a molecular weight of 264.37, logP of 2.62, molecular refractivity of 78.68, TPSA of 41.57, 1 hydrogen bond donor, 4 hydrogen bond acceptors, 8 rotatable bonds, 0 chiral centers, 19 heavy atoms, a formal charge of 0, 1 total ring, and aliphatic_long_chain structural alerts.

The most similar non-approved drugs to Compound X are:

- Drug 1 with a similarity score of 0.92, having a molecular weight of 281.42, logP of 2.68, molecular refractivity of 78.26, TPSA of 37.38, 0 hydrogen bond donors, 3 hydrogen bond acceptors, 4 rotatable bonds, 0 chiral centers, 19 heavy atoms, a formal charge of 0, 2 total rings, and no structural alerts.
- Drug 2 with a similarity score of 0.92, having a molecular weight of 315.84, logP of 4.38, molecular refractivity of 94.71, TPSA of 12.47, 0 hydrogen bond donors, 2 hydrogen bond acceptors, 3 rotatable bonds, 0 chiral centers, 22 heavy atoms, a formal charge of 0, 3 total rings, and no structural alerts.
- Drug 3 with a similarity score of 0.92, having a molecular weight of 341.45, logP of 3.24, molecular refractivity of 100.2, TPSA of 58.56, 2 hydrogen bond donors, 4 hydrogen bond acceptors, 11 rotatable bonds, 1 chiral center, 25 heavy atoms, a formal charge of 0, 2 total rings, and aliphatic_long_chain structural alerts.
- Drug 4 with a similarity score of 0.92, having a molecular weight of 295.85, logP of 4.17, molecular refractivity of 85.5, TPSA of 12.47, 0 hydrogen bond donors, 2 hydrogen bond acceptors, 8 rotatable bonds, 0 chiral centers, 20 heavy atoms, a formal charge of 0, 2 total rings, and aliphatic_long_chain structural alerts.
- Drug 5 with a similarity score of 0.91, having a molecular weight of 313.87, logP of 4.59, molecular refractivity of 97.79, TPSA of 3.24, 0 hydrogen bond donors, 1 hydrogen bond acceptor, 3 rotatable bonds, 0 chiral centers, 22 heavy atoms, a formal charge of 0, 3 total rings, and styrene_A(13) structural alerts.

Given that most of the similar approved drugs have high similarity scores (> 0.95) and similar properties to Compound X, and considering the low structural alerts, it is likely that Compound X has a good chance of approval.

On the other hand, the similar non-approved drugs have similarity scores that are generally lower than the approved drugs and have some differences in properties such as logP, TPSA, and structural alerts. While some of the non-approved drugs have high similarity scores, the overall properties of Compound X suggest that it is more likely to be approved.

After analyzing the data, I conclude that Compound X has a higher likelihood of being approved due to its similarity to approved drugs and its properties.

</think>
<label>
Approved
</label>
<score>
0.82
</score>


Extracted


:
approved


Score


:
0.82
  5%|â–Œ         | 1/20 [03:05<58:48, 185.72s/it]                                               {'loss': 0.0, 'grad_norm': 0.25472185015678406, 'learning_rate': 0.0, 'rewards/xmlcount_reward_func': -2.1197500228881836, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.375, 'rewards/correctness_reward_func': 1.5, 'rewards/int_score_reward_func': 0.0, 'rewards/confident_score_func': 0.0, 'reward': -0.24475005269050598, 'reward_std': 2.1508705615997314, 'completion_length': 609.75, 'kl': 0.0, 'epoch': 0.0}
  5%|â–Œ         | 1/20 [03:05<58:48, 185.72s/it]--------------------
Question:

            I have developed a model that can predict the drug approval of compound X.
            This model outputs two lists containting the properties of most similar approved and unapproved modelcules
            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 1486.57, 'LogP': -7.85, 'Molecular Refractivity': 364.21, 'TPSA': 488.88, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 100, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.88, 'Rdkit information': {'Molecular Weight': 1500.55, 'LogP': -7.76, 'Molecular Refractivity': 364.76, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 2: { 'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 1394.59, 'LogP': -3.4, 'Molecular Refractivity': 355.87, 'TPSA': 494.22, 'Hydrogen Bond_Donors': 17, 'Hydrogen_Bond Acceptors': 21, 'Rotatable Bonds': 34, 'Chiral Centers': 10, 'Heavy Atoms': 97, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 3: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 511.51, 'LogP': -3.37, 'Molecular Refractivity': 120.12, 'TPSA': 225.76, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 35, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 4: { 'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 5: { 'similarity score': 0.72, 'Rdkit information': {'Molecular Weight': 681.75, 'LogP': -4.68, 'Molecular Refractivity': 119.85, 'TPSA': 213.94, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 20, 'Chiral Centers': 1, 'Heavy Atoms': 38, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.89, 'Rdkit information': {'Molecular Weight': 1609.57, 'LogP': -7.38, 'Molecular Refractivity': 359.0, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 2: { 'similarity score': 0.75, 'Rdkit information': {'Molecular Weight': 573.67, 'LogP': -0.46, 'Molecular Refractivity': 150.45, 'TPSA': 199.95, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 16, 'Chiral Centers': 3, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 2, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 4: { 'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 752.23, 'LogP': -0.18, 'Molecular Refractivity': 179.0, 'TPSA': 256.90, 'Hydrogen Bond_Donors': 6, 'Hydrogen_Bond Acceptors': 14, 'Rotatable Bonds': 13, 'Chiral Centers': 2, 'Heavy Atoms': 50, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'imine_1', 'Oxygen-nitrogen_single_bond', 'quaternary_nitrogen_2']}}, 5: { 'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 588.67, 'LogP': -1.97, 'Molecular Refractivity': 151.75, 'TPSA': 235.91, 'Hydrogen Bond_Donors': 8, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 9, 'Chiral Centers': 4, 'Heavy Atoms': 42, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain', 'imine_1', 'imine_2']}}}}
            


Answer


:
unapproved


Response


:
<think>
To determine the likelihood of compound X receiving regulatory approval, I will first compare its properties to those of the most similar approved and unapproved molecules. 

1. **Similarity to approved molecules**: The highest similarity score among approved molecules is 0.88, which suggests that compound X shares many structural features with approved drugs. This indicates that compound X might have a good chance of approval if its pharmacological properties are favorable.

2. **Similarity to unapproved molecules**: The highest similarity score among unapproved molecules is 0.89, which is even higher than the highest score among approved molecules. However, similarity alone is not a determining factor for approval. I need to consider the structural alerts, pharmacological properties, and other factors.

3. **Structural alerts**: Compound X has two structural alerts: 'Aliphatic_long_chain' and 'disulphide'. Both of these alerts are present in some of the most similar approved molecules, indicating that these structural features are not necessarily problematic.

4. **Pharmacological properties**: To determine the likelihood of approval, I need to consider other pharmacological properties, such as potency, efficacy, and toxicity. However, the provided information is limited to the properties listed in the dataset.

5. **Molecular weight**: Compound X has a molecular weight of 1486.57, which is relatively high compared to some of the most similar approved molecules.

6. **TPSA**: Compound X has a TPSA (Topological Polar Surface Area) of 488.88, which is higher than some of the most similar approved molecules.

7. **Hydrogen bond donors and acceptors**: Compound X has 14 hydrogen bond donors and 25 hydrogen bond acceptors, which is similar to some of the most similar approved molecules.

Considering all these factors, I'm going to take a cautious approach and assume that compound X has a good chance of approval. However, I would need more information about its pharmacological properties and efficacy to make a definitive decision.

</think>
<label>
approved
</label>
<score>
0.85
</score>

Note: The score reflects my relatively high confidence in the approval of compound X, but there are some uncertainties and missing information that could affect its actual approval status.


Extracted


:
approved


Score


:
0.85
Unsloth: Will smartly offload gradients to save VRAM!
 10%|â–ˆ         | 2/20 [07:00<1:04:22, 214.61s/it]                                                 {'loss': 0.0, 'grad_norm': 0.22545231878757477, 'learning_rate': 5e-05, 'rewards/xmlcount_reward_func': -2.158250093460083, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.5, 'rewards/correctness_reward_func': 0.75, 'rewards/int_score_reward_func': 0.0, 'rewards/confident_score_func': 0.0, 'reward': -0.9082499742507935, 'reward_std': 1.3272584676742554, 'completion_length': 796.25, 'kl': 0.0, 'epoch': 0.0}
 10%|â–ˆ         | 2/20 [07:00<1:04:22, 214.61s/it]--------------------
Question:

            I have developed a model that can predict the drug approval of compound X.
            This model outputs two lists containting the properties of most similar approved and unapproved modelcules
            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 448.45, 'LogP': 3.66, 'Molecular Refractivity': 111.28, 'TPSA': 97.12, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 5, 'Chiral Centers': 1, 'Heavy Atoms': 32, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 522.58, 'LogP': 2.01, 'Molecular Refractivity': 127.75, 'TPSA': 138.44, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 11, 'Rotatable Bonds': 10, 'Chiral Centers': 6, 'Heavy Atoms': 36, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 506.61, 'LogP': 4.94, 'Molecular Refractivity': 140.71, 'TPSA': 75.00, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 37, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 447.54, 'LogP': 2.97, 'Molecular Refractivity': 128.65, 'TPSA': 105.04, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 5, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 489.93, 'LogP': 5.54, 'Molecular Refractivity': 124.03, 'TPSA': 91.92, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 375.4, 'LogP': 1.98, 'Molecular Refractivity': 99.63, 'TPSA': 83.80, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 27, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 415.43, 'LogP': 3.75, 'Molecular Refractivity': 115.64, 'TPSA': 101.38, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 5, 'Chiral Centers': 1, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 560.65, 'LogP': 5.03, 'Molecular Refractivity': 156.83, 'TPSA': 85.52, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 41, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 573.68, 'LogP': 1.83, 'Molecular Refractivity': 152.15, 'TPSA': 179.64, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Sulfonic_acid_2']}}, 4: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 461.51, 'LogP': 3.61, 'Molecular Refractivity': 124.64, 'TPSA': 116.13, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 6, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['2-halo_pyridine']}}, 5: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 396.5, 'LogP': 2.28, 'Molecular Refractivity': 111.78, 'TPSA': 92.63, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 7, 'Chiral Centers': 1, 'Heavy Atoms': 29, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': ['N_oxide', 'quaternary_nitrogen_1']}}}}
            


Answer


:
unapproved


Response


:
<think>

To analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules, I first need to evaluate the properties of compound X and compare them to the properties of the most similar approved and non-approved drugs.

Comparing the properties of compound X to the most similar approved drugs:

- Compound X has a molecular weight of 448.45, logP of 3.66, and molecular refractivity of 111.28, which are within the range of the most similar approved drugs (e.g., molecular weight between 447.54 and 522.58, logP between 2.01 and 4.94).
- However, compound X has fewer hydrogen bond acceptors (8) compared to the most similar approved drugs (11 in the second most similar approved drug), which might affect its ability to form critical interactions with biological targets.
- Meanwhile, compound X has a smaller number of hydrogen bond donors (3) compared to some of the most similar approved drugs (e.g., 4 in the first most similar approved drug), which might also affect its activity.

Comparing the properties of compound X to the most similar non-approved drugs:

- Compound X has a logP of 3.66, which is lower than the logP of the most similar non-approved drugs (3.75 and above), suggesting that it might have better solubility and bioavailability.
- However, compound X has a lower molecular refractivity (111.28) compared to some of the most similar non-approved drugs (e.g., 115.64 and above), which might affect its interaction with biological targets.
- Furthermore, compound X has a larger number of hydrogen bond acceptors (8) compared to some of the most similar non-approved drugs (e.g., 7 in the first most similar non-approved drug), which might increase its ability to form critical interactions with biological targets.

Taking all these factors into account, compound X appears to share some characteristics with both approved and non-approved drugs. However, its smaller number of hydrogen bond donors and molecular refractivity compared to some of the most similar approved drugs, and its lower logP compared to some of the most similar non-approved drugs, raise some concerns about its drug-likeness and viability.

</think>

<label>

Based on the analysis, I would label compound X as **unapproved**, but with a relatively high level of uncertainty.

</label>

<score>

**0.45**

This score reflects the mixed indication of compound X's properties, where some characteristics are favorable and others are less so. The uncertainty of the score indicates that compound X is neither strongly approved nor strongly unapproved.

</score>


Extracted


:
based on the analysis, i would label compound x as **unapproved**, but with a relatively high level of uncertainty.


Score


:
**0.45**

This score reflects the mixed indication of compound X's properties, where some characteristics are favorable and others are less so. The uncertainty of the score indicates that compound X is neither strongly approved nor strongly unapproved.
 15%|â–ˆâ–Œ        | 3/20 [10:08<57:18, 202.28s/it]                                                 {'loss': 0.0, 'grad_norm': 0.18409360945224762, 'learning_rate': 4.965903258506806e-05, 'rewards/xmlcount_reward_func': -1.0542500019073486, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.25, 'rewards/correctness_reward_func': 0.0, 'rewards/int_score_reward_func': 0.0, 'rewards/confident_score_func': 0.0, 'reward': -0.8042500019073486, 'reward_std': 1.130825400352478, 'completion_length': 464.0, 'kl': 7.594162889290601e-05, 'epoch': 0.0}
 15%|â–ˆâ–Œ        | 3/20 [10:08<57:18, 202.28s/it]slurmstepd: error: *** JOB 110566 ON en-7-1 CANCELLED AT 2025-04-14T05:47:22 ***
#################################################
Panthera Cluster
Job 110566 for user 'u111169'
Finished at: Mon Apr 14 05:47:26 +0330 2025
Job details file : ~/JobSummary/110566.out
================================================
